ArticleClinical drug investigation2025
Comment on: "An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom".
Sue Perera et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.